Identity
- Trade Name
- InQu FDA UDI
- Generic Name
- Synthetic bone graft FDA UDI
- Device Name
- lnQu is a resorbable bone void filler intended to fill bony gaps or voids that are not intrinsic to the stability of the bony structure.InQu is intended for use as a bone graft substitute in the skeletal system (extremities and pelvis). lnQu is indicated for use as a bone graft extender in the spine when combined with bone autograft. These defects may be surgically created or result from traumatic injury to the bone. FDA UDI
- Model / Reference
- Granules FDA UDI
- Description
- lnQu is a resorbable bone void filler intended to fill bony gaps or voids that are not intrinsic to the stability of the bony structure.InQu is intended for use as a bone graft substitute in the skeletal system (extremities and pelvis). lnQu is indicated for use as a bone graft extender in the spine when combined with bone autograft. These defects may be surgically created or result from traumatic injury to the bone. FDA UDI
Identifiers
- Catalog Number
- IQSP-GR-130 FDA UDI
- Primary DI / UDI-DI
- M896IQSPGR1300 FDA UDI
- 510(k) Number
- K071428 FDA UDI
- FDA Product Code
- MQV FDA UDI
- GMDN Term
- Synthetic bone graft FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 888.3045 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
Yes
FDA UDI
Single Use
Yes
FDA UDI
Implantable
Yes
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Synthetic bone graft
InQu by Arteriocyte Medical Systems, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Synthetic bone graft.
- Beta-bsm ® — Etex Corp. · Class II
- BIO2 TECHNOLOGIES — Bio2 Technologies, Inc. · Class II
- Bicera® Resorbable Bone Substitute — Wiltrom Co., Ltd. (Chutung) · Class II
- OsseoSculpt Moldable ABG, 3cc — Biogennix, LLC · Class II
- Montage Settable Bone Putty — ABYRX, INC. · Class II
- IngeniOS HA — curasan AG · Class II
- Osbone Dental — curasan AG · Class II
- Bicera® Resorbable Bone Substitute — WILTROM INC. · Class II
Cleared under the same submission
K071428 also covers:
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Arteriocyte Medical Systems, Inc.
Sources (1)
- FDA UDI 51fa3543-dfad-497e-8efe-6de17b8441c1 35 fields · synced May 30, 2026